Figure 2From: Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder AA:EPA ratio changes at week 0, week 4 and week 8.* *Each line represents a participant's AA:EPA ratio from baseline to week 4 and week 8, dashed lines represent the participants whose EPA/DHA concentrate dosage was not changed at week 4.Back to article page